12/06/2026
🔬We're excited to share that our 2026 Research Grants Round, focused on the promising field of immunotherapy, attracted 15 high quality Letters of Intent (LOIs) from researchers passionate about developing new approaches to treating neuroblastoma.
These are now being carefully reviewed by our expert Scientific Advisory Board (SAB) as part of our rigorous assessment process. Their role is to identify the most promising research projects with the potential to improve outcomes and quality of life for children affected by neuroblastoma.
A number of the 15 LOIs will be selected to move forward to full proposals for further assessment by world-wide experts with final decisions made in November.
To everyone who has sponsored, donated, fundraised, participated in any of our events, or supported our mission in any way - thank you.
Your support means we can help drive the next generation of research breakthroughs.
https://www.neuroblastoma.org.au/apply-for-a-grant